Cubist Systematic Strategies, LLC Adma Biologics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.6 Billion
  • Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 483,797 shares of ADMA stock, worth $9.65 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
483,797
Previous 384,076 25.96%
Holding current value
$9.65 Million
Previous $6.59 Million 45.73%
% of portfolio
0.06%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$15.44 - $20.61 $1.54 Million - $2.06 Million
99,721 Added 25.96%
483,797 $9.6 Million
Q4 2024

Feb 14, 2025
BUY
$15.62 - $22.62 $6 Million - $8.69 Million
384,076 New
384,076 $6.59 Million
Q2 2024

Aug 14, 2024
SELL
$5.98 - $11.18 $3.4 Million - $6.35 Million
-567,758 Reduced 55.05%
463,685 $5.18 Million
Q1 2024

May 15, 2024
BUY
$4.4 - $6.74 $3.52 Million - $5.4 Million
800,512 Added 346.65%
1,031,443 $6.81 Million
Q4 2023

Feb 14, 2024
SELL
$3.08 - $4.52 $215,085 - $315,645
-69,833 Reduced 23.22%
230,931 $1.04 Million
Q3 2023

Nov 14, 2023
SELL
$3.47 - $4.61 $91,812 - $121,975
-26,459 Reduced 8.09%
300,764 $1.08 Million
Q2 2023

Aug 14, 2023
BUY
$3.12 - $4.22 $581,692 - $786,776
186,440 Added 132.43%
327,223 $1.21 Million
Q1 2023

May 15, 2023
BUY
$3.01 - $3.87 $56,142 - $72,183
18,652 Added 15.27%
140,783 $465,000
Q4 2022

Feb 14, 2023
BUY
$2.47 - $3.88 $301,663 - $473,868
122,131 New
122,131 $473,000
Q2 2022

Aug 15, 2022
SELL
$1.43 - $2.2 $454,085 - $698,592
-317,542 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.28 - $1.83 $166,069 - $237,427
129,742 Added 69.09%
317,542 $581,000
Q4 2021

Feb 14, 2022
BUY
$1.09 - $1.66 $204,702 - $311,748
187,800 New
187,800 $265,000
Q3 2021

Nov 15, 2021
SELL
$1.13 - $1.65 $70,606 - $103,098
-62,484 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.51 - $2.07 $28,967 - $39,710
19,184 Added 44.3%
62,484 $100,000
Q1 2021

May 17, 2021
BUY
$1.67 - $2.95 $72,311 - $127,735
43,300 New
43,300 $76,000
Q2 2020

Aug 14, 2020
SELL
$2.42 - $3.29 $14,752 - $20,055
-6,096 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.5 - $4.59 $9,144 - $27,980
6,096 New
6,096 $18,000

Others Institutions Holding ADMA

# of Institutions
378
Shares Held
188M
Call Options Held
2.53M
Put Options Held
696K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.92B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email